CLS — Celestica Income Statement
0.000.00%
Last trade - 00:00
- $5.43bn
- $5.95bn
- $7.96bn
- 96
- 74
- 96
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,888 | 5,748 | 5,635 | 7,250 | 7,961 |
Cost of Revenue | |||||
Gross Profit | 385 | 404 | 479 | 636 | 779 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,739 | 5,620 | 5,467 | 6,987 | 7,578 |
Operating Profit | 149 | 128 | 168 | 263 | 383 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 99.8 | 90.2 | 136 | 204 | 307 |
Provision for Income Taxes | |||||
Net Income After Taxes | 70.3 | 60.6 | 104 | 146 | 245 |
Net Income Before Extraordinary Items | |||||
Net Income | 70.3 | 60.6 | 104 | 146 | 245 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 70.3 | 60.6 | 104 | 146 | 245 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.245 | 0.426 | 0.834 | 1.22 | 2.13 |